Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Samrat Pharmachem Ltd

NSE: SAMRATPH · BSE: 530125 · Pharmaceuticals & Biotechnology · 15 announcements

Share price
₹239.05
Market cap
₹73.86 Cr
Revenue (annual)
₹289.7 Cr
Net profit (annual)
₹-3.31 Cr
P/E (TTM)
-33.5×Sector 47.4×
Promoter holding
49.09%+0.00% QoQ
FII holding
3.24%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

15:02 IST BSE
Board Meeting Date

Samrat Pharmachem Board Meeting Date

Samrat Pharmachem will hold a board meeting on November 14, 2026, to consider its unaudited quarterly financial results for the period ended September 2026.

16:15 IST BSE
Other Announcement

Samrat Pharmachem Other Announcement

Samrat Pharmachem Limited appointed M/s Divyesh J Shah & Associates as Statutory Auditors following the expiry of the previous auditor's tenure at the 34th Annual General Meeting.

16:37 IST BSE
Annual General Meeting

Samrat Pharmachem Annual General Meeting

Samrat Pharmachem Limited held its 34th Annual General Meeting on September 23, 2026. The meeting successfully transacted the business items outlined in the prior meeting notice.

20:37 IST BSE
Annual General Meeting

Samrat Pharmachem Annual General Meeting

Samrat Pharmachem will hold its 34th Annual General Meeting on September 23, 2026, via video conferencing. The company also announced book closure dates for shareholders.

20:04 IST BSE
Annual Report

Samrat Pharmachem Annual Report

Samrat Pharmachem filed its 34th Annual Report for FY 2025-26. The company's 34th AGM is scheduled for September 23, 2026, via video conferencing.

14:26 IST BSE
Business Update

Samrat Pharmachem Business Update

Samrat Pharmachem Ltd issued a duplicate share certificate to one shareholder. The issuance replaces 400 original shares that were lost.

15:44 IST BSE
Other Announcement

Samrat Pharmachem Other Announcement

Samrat Pharmachem appointed Divyesh J Shah & Associates as Statutory Auditors for five years. The term spans from the 34th to 39th Annual General Meeting.

Execution
5 years